---
title: "Multi-omics Analysis of Multiple Missions to Space Reveal a Theme of Lipid Dysregulation in Mouse Liver"
summary: "A comprehensive analysis of liver tissue from mice on multiple space missions reveals that spaceflight consistently disrupts lipid metabolism. These changes, driven by key regulators like HNF4α and PPARα, resemble the early stages of non-alcoholic fatty liver disease (NAFLD), highlighting a potential health risk for long-duration space travel."
publishDate: 2019-12-16T12:00:00Z
authors: ["Beheshti A", "Chakravarty K", "Fogle H", "Fazelinia H", "da Silveira WA", "Boyko V", "Lai Polo SH", "Saravia-Butler AM", "Hardiman G", "Taylor D", "Galazka J", "Costes SV"]
tags: ["Metabolomics", "Proteomics", "Genetics", "Microgravity", "Animals"]
organisms: ["Mice"]
experimentType: "Spaceflight"
featuredImage: "https://res.cloudinary.com/dukrtt0na/image/upload/v1759679816/vb8gplq6md4kxwxfyaza.jpg"
readTime: 4
priority: "high"
consensusLevel: "high"
knowledgeGaps: ["The relative contributions of microgravity versus space radiation to liver changes", "Whether the observed lipid dysregulation is reversible upon return to Earth", "Long-term progression of these changes to more severe liver disease like fibrosis", "Effectiveness of targeted countermeasures against HNF4α or PPARα pathways"]
doi: "10.1038/s41598-019-55869-2"
journal: "Scientific Reports"
url: "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985101/"

chartData:
  type: "none"
  data:
    labels:
      - "OSD-195 (21 DB)"
    datasets:
      - label: "Correlation"
  options:
    responsive: true
---
# Introduction
The liver is a vital organ that performs critical metabolic functions, but the spaceflight environment—including microgravity and radiation—imposes significant stress on it. While previous studies have noted changes in liver function, the consistent molecular mechanisms driving these adaptations have remained unclear. This study addresses this gap by integrating data from multiple spaceflight missions to identify common biological themes and key regulatory networks that are altered in the liver during space travel.

## Research Objective
The primary goal of this research was to conduct a multi-omics systems biology analysis to uncover the core molecular responses of the mouse liver to spaceflight. Specific objectives included:
- To integrate and analyze transcriptomic, proteomic, and metabolomic datasets from mouse liver tissue collected across different spaceflight missions.
- To identify consistent and significantly altered biological pathways and molecular regulators.
- To determine if the observed molecular changes correspond to known liver pathologies, such as non-alcoholic fatty liver disease (NAFLD).

## Key Findings
The integrated analysis revealed a strong, consistent pattern of metabolic disruption across all missions studied.
- **Lipid Dysregulation is a Central Theme:** The most significant and consistent finding was the disruption of lipid metabolism. This was evidenced by changes in genes, proteins, and metabolites involved in fatty acid processing.
- **Activation of Key Metabolic Regulators:** The study identified **HNF4α** as a key upstream regulator driving these changes. This led to the activation of the **PPARα/RXRα signaling pathway**, a master regulator of fatty acid oxidation.
- **Increased Fatty Acid Oxidation:** Activation of PPARα resulted in the upregulation of genes responsible for breaking down fatty acids, a state that can lead to cellular stress if not properly managed.
- **Oxidative Stress Response:** The analysis showed a corresponding activation of the **NRF2-mediated oxidative stress response**, indicating that the liver cells were actively trying to combat damage from increased metabolic activity.
- **Similarities to NAFLD:** The combination of lipid dysregulation, altered fatty acid oxidation, and oxidative stress strongly mirrors the molecular signatures seen in the early stages of **non-alcoholic fatty liver disease (NAFLD)**.
- **Consistent Across Missions:** These molecular signatures were consistently observed in liver samples from mice flown on Space Shuttle missions (STS-131, STS-135) and the Bion-M1 mission, despite differences in mission duration and hardware.

## Methodology
- **Organisms:** Liver tissue samples were analyzed from female C57BL/6 mice.
- **Experimental Conditions:** The study utilized archived data from the NASA GeneLab database, encompassing multiple spaceflight experiments with durations ranging from **13 to 30 days**. This included both spaceflight (FLT) animals and ground control (GC) counterparts.
- **Key Techniques:** A powerful **multi-omics approach** was used, integrating data from **transcriptomics** (gene expression), **proteomics** (protein levels), and **metabolomics** (metabolite levels). Advanced bioinformatics tools, including Ingenuity Pathway Analysis (IPA), were used to identify key regulators and affected biological pathways.

## Importance for Space Missions
This study's findings are critical for planning long-duration missions, such as those to Mars.
- **Identifies a Health Risk:** The research strongly suggests that astronauts may be at an increased risk of developing liver stress and conditions similar to NAFLD, which could compromise health and mission success.
- **Informs Medical Monitoring:** The identified molecular pathways provide specific biomarkers that could be used for monitoring astronaut liver health before, during, and after missions.
- **Guides Countermeasure Development:** By pinpointing **HNF4α and PPARα** as key drivers, this research provides specific targets for developing countermeasures, such as specialized diets, supplements (e.g., antioxidants), or pharmaceuticals, to protect liver function.

## Knowledge Gaps & Future Research
While this study provides a robust molecular picture, several key questions remain.
- The distinct effects of microgravity versus space radiation on the liver need to be disentangled.
- It is unknown if these NAFLD-like changes are transient and reversible upon return to Earth or if they persist and potentially worsen.
- Further research is needed to determine if these early-stage changes could progress to more severe liver conditions like steatohepatitis or fibrosis during extended missions.
- Studies are required to test the efficacy of targeted countermeasures aimed at mitigating oxidative stress and regulating the HNF4α/PPARα pathways in a spaceflight environment.

## Results
By integrating data from multiple missions, this study provides compelling evidence that spaceflight consistently triggers a state of lipid dysregulation and oxidative stress in the mouse liver, closely resembling the molecular pathology of early-stage NAFLD. This unified finding elevates liver health as a significant concern for long-duration space exploration and provides a clear, data-driven foundation for developing targeted health monitoring strategies and effective countermeasures to ensure the well-being of future astronauts.